Funding for this research was provided by:
Universidade de Macau (MYRG2019-00066-FHS)
the National Science and Technology Major Project for investigational new drug (2018ZX09201-014)
the Beijing Municipal Science & Technology Commission (Z181100001518005)
the Key Diagnosis and treatment Program of Suzhou (LCZX201615)
Received: 23 August 2020
Accepted: 13 November 2020
First Online: 18 December 2020
Ethics approval and consent to participate
: All participants provided written informed consent. The study protocol was approved by the ethics committee of the University of Macau, China.
: Approval of the final version for publication: all co-authors and all participants.
: The authors have no conflicts of interest to declare.